Therefore, in non-small cell lung cancer, it can inhibit the activeness of HSF1 and PSMD10 in the ATG7 promoter, thus inhibiting ATG7 transcription [26]. This evidence concerns the gene ATG7 and non-small cell lung carcinoma.